1. Home
  2. Browse Decisions
  3. F.4th
  4. 82 F.4th
  5. 82 F.4th 1196 (2023)
 

FEDERAL TRADE COMMISSION v. ENDO PHARMACEUTICALS

No. 22-5137.

82 F.4th 1196 (2023)

FEDERAL TRADE COMMISSION, Appellant, v. ENDO PHARMACEUTICALS INC., et al., Appellees.

United States Court of Appeals, District of Columbia Circuit.

Decided August 25, 2023.

Attorney(s) appearing for the Case

Mark S. Hegedus , Attorney, Federal Trade Commission, argued the cause for appellant. With him on the briefs were Anisha S. Dasgupta , General Counsel, and Joel Marcus , Deputy General Counsel.

George G. Gordon argued the cause for appellees Endo Pharmaceuticals Inc., et al. With him on the brief were Michael H. McGinley , Julia Chapman , and John P. McClam .

Jay P. Lefkowitz argued the cause for appellees Impax Laboratories, LLC, et al. With him on the brief were Devora W. Allon , Kevin Neylan , and James R.P. Hileman . Evelyn Blacklock entered an appearance.

Before: Srinivasan, Chief Judge, Millett and Childs, Circuit Judges.

The Federal Trade Commission Act, 15 U.S.C. §§ 41-58 (FTC Act), authorizes the Federal Trade Commission (the Commission) to investigate and prevent "unfair methods of competition" that affect commerce, see id. § 45(a)(2). In this matter, the Commission appeals the district court's dismissal of claims...

Let's get started

Leagle.com

Welcome to the leading source of independent legal reporting
Sign on now to see your case.
Or view more than 10 million decisions and orders.

  • Updated daily.
  • Uncompromising quality.
  • Complete, Accurate, Current.

Listed below are the cases that are cited in this Featured Case. Click the citation to see the full text of the cited case. Citations are also linked in the body of the Featured Case.

Cited Cases

  • No Cases Found

Listed below are those cases in which this Featured Case is cited. Click on the case name to see the full text of the citing case.

Citing Cases